These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17381375)

  • 21. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.
    Mertz GJ; Miedzinski L; Goade D; Pavia AT; Hjelle B; Hansbarger CO; Levy H; Koster FT; Baum K; Lindemulder A; Wang W; Riser L; Fernandez H; Whitley RJ;
    Clin Infect Dis; 2004 Nov; 39(9):1307-13. PubMed ID: 15494907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral treatment of SARS: can we draw any conclusions?
    Zhaori G
    CMAJ; 2003 Nov; 169(11):1165-6. PubMed ID: 14638651
    [No Abstract]   [Full Text] [Related]  

  • 24. Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    J Gastroenterol; 2004 Nov; 39(11):1090-4. PubMed ID: 15580403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
    Lau AC; So LK; Miu FP; Yung RW; Poon E; Cheung TM; Yam LY
    Respirology; 2004 Jun; 9(2):173-83. PubMed ID: 15182266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study.
    Auyeung TW; Lee JS; Lai WK; Choi CH; Lee HK; Lee JS; Li PC; Lok KH; Ng YY; Wong WM; Yeung YM
    J Infect; 2005 Aug; 51(2):98-102. PubMed ID: 16038758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS: pharmacotherapy.
    Tsang K; Zhong NS
    Respirology; 2003 Nov; 8 Suppl():S25-30. PubMed ID: 15018130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis.
    Rezvani M; Koren G
    Reprod Toxicol; 2006 Jan; 21(1):113-5. PubMed ID: 16122903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
    Tsui PT; Kwok ML; Yuen H; Lai ST
    Emerg Infect Dis; 2003 Sep; 9(9):1064-9. PubMed ID: 14519241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.
    Soo YO; Cheng Y; Wong R; Hui DS; Lee CK; Tsang KK; Ng MH; Chan P; Cheng G; Sung JJ
    Clin Microbiol Infect; 2004 Jul; 10(7):676-8. PubMed ID: 15214887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with critical-care healthcare workers' adherence to recommended barrier precautions during the Toronto severe acute respiratory syndrome outbreak.
    Shigayeva A; Green K; Raboud JM; Henry B; Simor AE; Vearncombe M; Zoutman D; Loeb M; McGeer A;
    Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1275-83. PubMed ID: 17926279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
    Chiu WK; Cheung PC; Ng KL; Ip PL; Sugunan VK; Luk DC; Ma LC; Chan BH; Lo KL; Lai WM
    Pediatr Crit Care Med; 2003 Jul; 4(3):279-83. PubMed ID: 12831407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
    Jones BM; Ma ES; Peiris JS; Wong PC; Ho JC; Lam B; Lai KN; Tsang KW
    Clin Exp Immunol; 2004 Mar; 135(3):467-73. PubMed ID: 15008980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.
    Gaeta GB; Precone DF; Felaco FM; Bruno R; Spadaro A; Stornaiuolo G; Stanzione M; Ascione T; De Sena R; Campanone A; Filice G; Piccinino F
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1633-9. PubMed ID: 12197842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia management in patients with chronic viral hepatitis C.
    Hynicka LM; Heil EL
    Ann Pharmacother; 2013 Feb; 47(2):228-36. PubMed ID: 23386076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.
    Lindahl K; Stahle L; Bruchfeld A; Schvarcz R
    Hepatology; 2005 Feb; 41(2):275-9. PubMed ID: 15660393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened?
    Ofner-Agostini M; Wallington T; Henry B; Low D; McDonald LC; Berger L; Mederski B; ; Wong T
    Can Commun Dis Rep; 2008 Feb; 34(2):1-11. PubMed ID: 18404809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis in a SARS outbreak.
    Wong CY; Wong KY; Law TS; Shum TT; Li YK; Pang WK
    J Chin Med Assoc; 2004 Nov; 67(11):579-82. PubMed ID: 15720073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients.
    Lee SS; Roberts SK; Berak H; Dusheiko GM; Harley HA; Gane EJ; Husa P; Horsmans YJ; Hadziyannis SJ; Jenny Heathcote E; Messinger D; Tatsch F; Han KH; Ferenci P
    Liver Int; 2012 Sep; 32(8):1270-7. PubMed ID: 22621707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.